FlaggedRx← Medication recall checkHome
Class II · ModerateActive recall

SEMAGLUTIDE 7.5mg (5mg/mL)

Could cause temporary or reversible harm; serious harm is unlikely.

Does this affect you?
Check your lot numberLot: AC-017273, Exp. 12/12/2026.
Where it was soldNationwide within the U.S
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.

What happened

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

What to do

  1. Check the lot number and expiry on your medicine against the recall above.
  2. Talk to your pharmacist or doctor before changing anything — don't stop on your own.
  3. Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).

Who makes it

Distributed by / forApollo Care, LLC
NDC71170-721-01
Show the full FDA record
Full product labelSEMAGLUTIDE 7.5mg (5mg/mL), Glycine 7.5 mg (5mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-721-01
Recalling firmApollo Care, LLC
DistributionNationwide within the U.S
Quantity250 vials.
Recall initiated2026-07-29
Report date2026-08-19
Recall completed—
Recall numberD-0755-2026
ClassificationClass II
FDA statusOngoing
Origin on fileColumbia MO United States

Related

Semaglutide recallsRecent drug recallsCheck another medication

Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗

This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.